Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients

Table 1

Demographic and clinical parameters of CD patients.

Parameter	Patients	Controls
No.	21	20
Age	6-17	6-17
Sex^a	15 : 5	14 : 6
Ethnicity	French Caucasian	French Caucasian
Disease activity	9 newly diagnosed	—
	6 relapsed	—
	6 in remission	—
Drugs	15 none	—
	6 under treatment	—

^aMale : female ratio. The newly diagnosed patients had not received any treatment. The relapsed patients were previously treated with azathioprine, prednisone, anakinra, and natalizumab in different combinations. However, they were currently not receiving any treatment. The patients in remission were currently receiving TNF-α blocking antibodies (infliximab or adalimumab), prednisone, or azathioprine.